Pediatric Electrocutaneous Analgesia for Children Experiencing Neuropathic Pain
Not yet recruitingNot applicableNCT07264920
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
This is a study evaluating the Scrambler Therapy device as a non-invasive treatment for neuropathic pain in pediatric oncology patients with metastatic bone disease. The primary goal is to assess changes in pain intensity and medication use, aiming to improve quality of life and reduce reliance on systemic pain medications.
Study details
- Official title
- Pediatric Electrocutaneous Analgesia for Children Experiencing Neuropathic Pain
- Conditions
- Interventions
- Device: Scrambler Therapy MC-5A Device
- Sponsor
- Johns Hopkins University
- Start date
- 2026-10
- Primary completion
- 2030-01
- Sex
- All
- Age range
- from 5 Years to 26 Years
- Results posted
- No results posted in this snapshot
- Countries
- United States
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Able to verbalize pain scores * Oncology patients with acute and/or chronic pain Exclusion Criteria: * Patients with Implantable Devices * Epilepsy * Pregnancy * A history of myocardial infarction or ischemic heart disease within the past six months * History of severe heart arrhythmia or equivalent heart disease * Open Wounds or Infections at site of electrode placement * A history of intolerance to transcutaneous electronic nerve stimulation
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT07264920